🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of acetaminophen, asserting the companies hid safety concerns that the pain reliever created to pediatric neurological development.

The court filing arrives four weeks after Donald Trump promoted an unverified association between taking acetaminophen - also known as paracetamol - while pregnant and autism in offspring.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication approved for expectant mothers, and Kenvue, which presently makes it.

In a statement, he said they "betrayed America by making money from pain and marketing drugs ignoring the dangers."

The company asserts there is insufficient reliable data linking acetaminophen to autism.

"These manufacturers deceived for years, deliberately risking countless individuals to increase profits," Paxton, from the Republican party, declared.

Kenvue commented that it was "seriously troubled by the spread of false claims on the reliability of paracetamol and the possible consequences that could have on the welfare of US mothers and children."

On its website, Kenvue also mentioned it had "regularly reviewed the relevant science and there is lacking reliable evidence that indicates a proven link between using acetaminophen and autism."

Organizations acting on behalf of physicians and healthcare providers agree.

The leading OB-GYN organization has declared paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to manage pain and fever, which can present significant medical dangers if left untreated.

"In more than two decades of studies on the utilization of paracetamol in gestation, zero credible investigations has conclusively proven that the use of paracetamol in any stage of gestation results in neurodevelopmental disorders in offspring," the association commented.

This legal action references latest statements from the former administration in claiming the drug is potentially dangerous.

Recently, the former president raised alarms from public health officials when he advised women during pregnancy to "struggle intensely" not to use acetaminophen when ill.

Federal regulators then released a statement that physicians should consider limiting the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism in children has remains unverified.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in April to undertake "extensive scientific investigation" that would identify the source of autism spectrum disorder in a matter of months.

But specialists warned that finding a unique factor of autism - thought by researchers to be the result of a complicated interplay of inherited and external influences - would be difficult.

Autism is a category of lifelong neurodivergence and disability that affects how persons experience and relate to the world, and is recognized using physician assessments.

In his court filing, Paxton - aligned with the former president who is seeking US Senate - claims Kenvue and J&J "intentionally overlooked and tried to quiet the science" around paracetamol and autism spectrum disorder.

This legal action seeks to make the corporations "eliminate any promotional materials" that asserts acetaminophen is safe for pregnant women.

The court case echoes the concerns of a assembly of guardians of minors with autism and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in two years ago.

A federal judge rejected the lawsuit, declaring studies from the family's specialists was not conclusive.